London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
Oxford Nanopore Technologies
Max Bloomfield
- Job title
- Institution
- Awanui Laboratories Wellington, New Zealand
- Biography
Dr Max Bloomfield is a clinical microbiologist and infectious diseases physician working in Wellington, New Zealand. He is actively involved with hospital infection control, epidemiology, and antimicrobial resistance from both a clinical and research standpoint. A key interest of his relates to the practical translation of technologies, such as Oxford Nanopore sequencing, to enable effective, pragmatic, and sustainable use in the clinical space.
- Recent publications
Bloomfield, M. et al. The need for speed: ultra-rapid high-resolution outbreak analysis in a front-line hospital microbiology laboratory. Journal of Hospital Infection 168:48–57 (2026).
DOI: 10.1016/j.jhin.2025.11.020Bloomfield, M. et al. Resolving a neonatal intensive care unit outbreak of methicillin-resistant Staphylococcus aureus to the single-nucleotide variant level using Oxford Nanopore simplex reads and HERRO error correction. Journal of Hospital Infection 163:72–77 (2025).
DOI: 10.1016/j.jhin.2025.06.004White, R.T. et al. The rapid detection of a neonatal unit outbreak of a wild-type Klebsiella variicola using decentralized Oxford Nanopore sequencing. Antimicrob. Resist. Infect. Control 14(6) (2025).
DOI: 10.1186/s13756-025-01529-2Bloomfield M. et al. Early identification of a ward-based outbreak of Clostridioides difficile using prospective multilocus sequence type-based Oxford Nanopore genomic surveillance*. Infection Control & Hospital Epidemiology* 45(9):1057–1063 (2024).
DOI: 10.1017/ice.2024.77Bloomfield, M. et al. Oxford nanopore next generation sequencing in a front-line clinical microbiology laboratory without on-site bioinformaticians. Pathology 56(3):444–447 (2024).
DOI: 10.1016/j.pathol.2023.07.014White, R. T. et al. Rapid identification and subsequent contextualization of an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit using nanopore sequencing. Microbial Genomics 10(7) (2024).
DOI: 10.1099/mgen.0.001273
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
